Virtanen T - Search Results

1

Virtanen T, Kinnunen T. Virtanen T, et al. Clin Allergy Immunol. 2008;21:201-18. Clin Allergy Immunol. 2008. PMID: 18828506 Review. No abstract available.

2

Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Immonen AK, Taivainen AH, Närvänen AT, Kinnunen TT, Saarelainen SA, Rytkönen-Nissinen MA, Virtanen TI. Immonen AK, et al. Among authors: virtanen ti. Immunology. 2007 Jan;120(1):38-46. doi: 10.1111/j.1365-2567.2006.02475.x. Immunology. 2007. PMID: 17233739 Free PMC article.

3

Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues.

Saarelainen SA, Kinnunen TT, Buhot C, Närvänen AT, Kauppinen AK, Rytkönen-Nissinen MA, Maillere B, Virtanen TI. Saarelainen SA, et al. Among authors: virtanen ti. Immunology. 2008 Mar;123(3):358-66. doi: 10.1111/j.1365-2567.2007.02699.x. Epub 2007 Oct 16. Immunology. 2008. PMID: 17944901 Free PMC article.

4

Characterization of human memory CD4(+) T-cell responses to the dog allergen Can f 4.

Rönkä AL, Kinnunen TT, Goudet A, Rytkönen-Nissinen MA, Sairanen J, Kailaanmäki AH, Randell JT, Maillère B, Virtanen TI. Rönkä AL, et al. Among authors: virtanen ti. J Allergy Clin Immunol. 2015 Oct;136(4):1047-54.e10. doi: 10.1016/j.jaci.2015.02.025. Epub 2015 Apr 3. J Allergy Clin Immunol. 2015. PMID: 25843313

5

The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells.

Kinnunen T, Buhot C, Närvänen A, Rytkönen-Nissinen M, Saarelainen S, Pouvelle-Moratille S, Rautiainen J, Taivainen A, Maillère B, Mäntyjärvi R, Virtanen T. Kinnunen T, et al. Among authors: virtanen t. Eur J Immunol. 2003 Jun;33(6):1717-26. doi: 10.1002/eji.200322952. Eur J Immunol. 2003. PMID: 12778490 Free article.

6

Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy.

Kinnunen T, Jutila K, Kwok WW, Rytkönen-Nissinen M, Immonen A, Saarelainen S, Närvänen A, Taivainen A, Virtanen T. Kinnunen T, et al. Among authors: virtanen t. J Allergy Clin Immunol. 2007 Apr;119(4):965-72. doi: 10.1016/j.jaci.2007.01.011. Epub 2007 Mar 1. J Allergy Clin Immunol. 2007. PMID: 17335888

7

Not all proteins are created allergens.

Virtanen T, Kinnunen T. Virtanen T, et al. J Allergy Clin Immunol. 2007 Sep;120(3):724; author reply 724-5. doi: 10.1016/j.jaci.2007.04.020. Epub 2007 May 25. J Allergy Clin Immunol. 2007. PMID: 17532035 No abstract available.

8

Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.

Juntunen R, Liukko A, Taivainen A, Närvänen A, Durand G, Kauppinen A, Nieminen A, Rytkönen-Nissinen M, Saarelainen S, Maillère B, Virtanen T, Kinnunen T. Juntunen R, et al. Among authors: virtanen t. Mol Immunol. 2009 Oct;46(16):3320-7. doi: 10.1016/j.molimm.2009.07.022. Epub 2009 Aug 22. Mol Immunol. 2009. PMID: 19700193

9

Differential CD4+ T-cell responses of allergic and non-allergic subjects to the immunodominant epitope region of the horse major allergen Equ c 1.

Kailaanmäki A, Kinnunen T, Kwok WW, Rytkönen-Nissinen M, Randell J, Virtanen T. Kailaanmäki A, et al. Among authors: virtanen t. Immunology. 2014 Jan;141(1):52-60. doi: 10.1111/imm.12166. Immunology. 2014. PMID: 23991693 Free PMC article. Clinical Trial.

10

Single-cell characterization of dog allergen-specific T cells reveals T_H2 heterogeneity in allergic individuals.

Vandamme C, Rytkönen-Nissinen M, Lönnberg T, Randell J, Harvima RJ, Kinnunen T, Virtanen T. Vandamme C, et al. Among authors: virtanen t. J Allergy Clin Immunol. 2022 May;149(5):1732-1743.e15. doi: 10.1016/j.jaci.2021.11.018. Epub 2021 Dec 1. J Allergy Clin Immunol. 2022. PMID: 34863852 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page